|
|
|
|
|
|
|
|
"Certain groups of patients have been particularly hard hit: children, patients with rare cancers, patients who would profit greatly from international trials that optimise already existing treatments and which, therefore, do not find commercial sponsorship, and elderly patients with other health problems, including secondary cancers due to earlier treatments."
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.